Ares Genetics的封面图片
Ares Genetics

Ares Genetics

生物技术研究

Let's Take Antibiotic Stewardship To The Next Level. Please follow OpGen, our parent company, for updates.

关于我们

Ares Genetics - an OpGen Group Company - is developing DNA-based infectious disease services and solutions for drug response prediction to improve the way antimicrobial resistant (AMR) infections are diagnosed, and prevented or treated. Our innovative AI-powered and Machine Learning (ML) driven approach leverages the extensive, curated database ARESdb to comprehensively detect and determine the genetic profile of pathogens. Unlike conventional molecular assays, Ares Genetics solutions not only detect AMR markers but shed light on prevalence and diagnostic performance for these markers and predict how pathogens will respond to therapy. Imprint: https://www.ares-genetics.com/imprint Please follow OpGen, our parent company, for updates.

所属行业
生物技术研究
规模
11-50 人
总部
Vienna
类型
上市公司
创立
2017
领域
IT services 、Molecular Diagnostics、Molecular Epidemiology、Biomarker Discovery & Licensing、Data Solutions、Next Generation Sequencing、Assay Development、(Pre)-Clinical Solutions、Companion Diagnostics、Outbreak Monitoring、Antimicrobial Stewardship、Functional Analyses、Artificial Intelligence、Antimicrobial Resistance (AMR)和Sequencing Services

地点

Ares Genetics员工

动态

相似主页

查看职位

融资

Ares Genetics 共 1 轮

上一轮

种子轮

US$1,489,468.00

Crunchbase 上查看更多信息